During the past decade, Cardiovascular Research Foundation of Southern California conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiovascular Research Foundation of Southern California" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Cardiovascular Research Foundation of Southern California" are "Cardiovascular Disease" (2 trials), "ASCVD" (1 trials) and "Coronary Heart Disease (CHD)" (1 trials). Many other conditions were trialed in "Cardiovascular Research Foundation of Southern California" in a lesser frequency.

Most popular intervention types in "Cardiovascular Research Foundation of Southern California" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials) and "Evolocumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular Research Foundation of Southern California" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Cardiovascular Research Foundation of Southern California". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Cardiovascular Research Foundation of Southern California, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular Research Foundation of Southern California, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".